Literature DB >> 28667464

Can Neurochemical Changes of Mood Disorders Explain the Increase Risk of Epilepsy or its Worse Seizure Control?

Andres M Kanner1.   

Abstract

The existence of a bidirectional relation between mood disorders and epilepsy has been suggested by six population-based studies. Furthermore, three studies have associated a higher risk of treatment-resistant epilepsy with a history of depression preceding the onset of epilepsy. Common pathogenic mechanisms operant in depression and epilepsy may provide a possible explanation of these observations. This article reviews some of the leading pathogenic mechanisms of depression with respect to potential proconvulsant properties that may provide explanations for these phenomena.

Entities:  

Keywords:  Cortisol; GABA; Glutamate; Major depressive disorders; Serotonin; Treatment-resistant epilepsy

Mesh:

Year:  2017        PMID: 28667464     DOI: 10.1007/s11064-017-2331-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  79 in total

Review 1.  Major depression and activation of the inflammatory response system.

Authors:  M Maes
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE.

Authors:  Taufik R Taher; Michael Salzberg; Margaret J Morris; Sandra Rees; Terence J O'Brien
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

3.  Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis.

Authors:  Colin B Josephson; Mark Lowerison; Isabelle Vallerand; Tolulope T Sajobi; Scott Patten; Nathalie Jette; Samuel Wiebe
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

4.  Increased cortical GABA concentrations in depressed patients receiving ECT.

Authors:  Gerard Sanacora; Graeme F Mason; Douglas L Rothman; Fahmeed Hyder; James J Ciarcia; Robert B Ostroff; Robert M Berman; John H Krystal
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

5.  Increased levels of glutamate in brains from patients with mood disorders.

Authors:  Kenji Hashimoto; Akira Sawa; Masaomi Iyo
Journal:  Biol Psychiatry       Date:  2007-06-15       Impact factor: 13.382

6.  Predictors of psychiatric and seizure outcome following temporal lobe epilepsy surgery.

Authors:  Rebecca A Cleary; Pamela J Thompson; Zoe Fox; Jacqueline Foong
Journal:  Epilepsia       Date:  2012-08-06       Impact factor: 5.864

7.  An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

Authors:  Sheldon H Preskorn; Bryan Baker; Sheela Kolluri; Frank S Menniti; Michael Krams; Jaren W Landen
Journal:  J Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.153

8.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

9.  Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.

Authors:  Andréy Mazarati; Prabha Siddarth; Roger A Baldwin; Don Shin; Rochelle Caplan; Raman Sankar
Journal:  Brain       Date:  2008-06-17       Impact factor: 13.501

10.  Early life stress enhancement of limbic epileptogenesis in adult rats: mechanistic insights.

Authors:  Gaurav Kumar; Nigel C Jones; Margaret J Morris; Sandra Rees; Terence J O'Brien; Michael R Salzberg
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

View more
  6 in total

1.  Beyond depression: The impact of executive functioning on quality of life in patients with temporal lobe epilepsy.

Authors:  Tobin Ehrlich; Anny Reyes; Brianna M Paul; Vedang Uttarwar; Stephen Hartman; Kushagra Mathur; Yu-Hsuan A Chang; Manu Hegde; Jerry J Shih; Carrie R McDonald
Journal:  Epilepsy Res       Date:  2018-11-13       Impact factor: 3.045

2.  Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model.

Authors:  Yijun Shen; Weifeng Peng; Qinglan Chen; Bruce D Hammock; Junyan Liu; Dongyang Li; Jun Yang; Jing Ding; Xin Wang
Journal:  Brain Behav Immun       Date:  2019-07-12       Impact factor: 7.217

3.  Disease Modification in Epilepsy: Behavioural Accompaniments.

Authors:  Emilio Russo; Rita Citraro
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Environmental Enrichment and Brain Neuroplasticity in the Kainate Rat Model of Temporal Lobe Epilepsy.

Authors:  Vasavi R Gorantla; Sneha E Thomas; Richard M Millis
Journal:  J Epilepsy Res       Date:  2019-06-30

Review 5.  A Comprehensive Overview on Stress Neurobiology: Basic Concepts and Clinical Implications.

Authors:  Lívea Dornela Godoy; Matheus Teixeira Rossignoli; Polianna Delfino-Pereira; Norberto Garcia-Cairasco; Eduardo Henrique de Lima Umeoka
Journal:  Front Behav Neurosci       Date:  2018-07-03       Impact factor: 3.558

6.  Impact of COVID-19 Lockdown, during the Two Waves, on Drug Use and Emergency Department Access in People with Epilepsy: An Interrupted Time-Series Analysis.

Authors:  Ippazio Cosimo Antonazzo; Carla Fornari; Sandy Maumus-Robert; Eleonora Cei; Olga Paoletti; Sara Conti; Paolo Angelo Cortesi; Lorenzo Giovanni Mantovani; Rosa Gini; Giampiero Mazzaglia
Journal:  Int J Environ Res Public Health       Date:  2021-12-16       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.